Aggressive pricing strategies target the U.S. market, according to reports from Democrats on the House Oversight Committee. Enormous drug company profits are the primary driver of soaring prescription drug prices in America, according to a damning investigation that Democrats on the House Oversight Committee began releasing Wednesday. The first two reports in the investigation focus on Celgene …